Marina Biotech gains $15M for work on RNAi, advancing familial adenomatous polyposis drug
18 October 2011
Nancy Faigen
Please Login to read the full article.
18 October 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Alnylam adds over $80M to warchest to advance lead RNAi programmes
- Quark's siRNA again fails to charm public market: withdraws IPO offer
- Eleven Biotherapeutics: closer to the clinic with a protein for topical delivery in dry eye
- FDA makes it official: AstraZeneca's Iressa, Sanofi's Oforta NDAs withdrawn
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
